title: Drug repositioning in sarcomas and other rare tumors.
authors.affiliation: Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK.
authors.forename: Alex T J
authors.initials: ATJ
authors.lastname: Lee
authors.affiliation: Institute of Cancer Research, London, UK.
authors.forename: Paul H
authors.initials: PH
authors.lastname: Huang
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
authors.forename: Seth M
authors.initials: SM
authors.lastname: Pollack
authors.affiliation: Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: robin.jones4@nhs.net.
authors.forename: Robin L
authors.initials: RL
authors.lastname: Jones
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D058492:Drug Repositioning / Q000191:economics / Q000379:methods*; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use; D035583:Rare Diseases / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D011433:Propranolol
keywords: Angiosarcoma; Drug development; Drug repositioning; Sarcomas